New Zealand - engelsk - Ministry for Primary Industries

agrimm technologies ltd - trichoderma atroviride (strains ag1, ag2, ag3, ag5, ag11, ag15) - trichoderma atroviride (strains ag1, ag2, ag3, ag5, ag11, ag15) 5 b cfu/g - fungicide

New Zealand - engelsk - Ministry for Primary Industries

agrimm technologies ltd - trichoderma atroviride - trichoderma atroviride 500 m cfu/g - fungicide

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - trichoderma harzianum rifai isolate t-39 - wettable powder - trichoderma harzianum rifai isolate t-39 biological-organism-fungus active 0.0 p - fungicide - grapevine - grey mould - botrytis cinerea | botrytis blight | botrytis rot | bunch rot

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

organon pharma (uk) ltd - clotrimazole; betamethasone dipropionate - cutaneous cream - 10mg/1gram ; 640microgram/1gram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - clotrimazole; betamethasone dipropionate - cutaneous cream - 10mg/1gram ; 640microgram/1gram

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 59130 - dermal tissue reconstructive material, animal-derived - matriderm serves as a scaffold for tissue regeneration and modulates the formation of scar tissue. matriderm has excellent haemostyptic properties and thus reduces the risk of subgraft haematoma, for example,between the matrix and the wound bed. in addition, matriderm supports orderly healing and acts as a temporary adhesion barrier. matriderm is a three-dimensional matrix composed of native, structurally intact collagen fibrils and elastin. matriderm is used in combination with autologous split-thickness skin grafts for the reconstruction of deep dermal defects and full-thickness skin wounds in plastic reconstructive surgery and in the surgical treatment of burns, trauma and dermatological diseases. it may also be used in the treatment of poorly healing wounds requiring skin grafts (e.g. chronic wounds); for the reconstruction of mucosal defects and also under intact skin for the temporary separation of tissues, thereby preventing adherence, especially of tendons and their surrounding connective tissue, after injuries or surgical procedures. the aim of treatment with matriderm is to construct a neodermis,to improve the quality of reconstituted tissue, reduce scarring, prevent wound contraction and restore functionality.

Irland - engelsk - HPRA (Health Products Regulatory Authority)

dechra veterinary products a/s - fusidic acid; betamethasone valerate - gel - 0.5, 0.1 percent weight/weight - betamethasone and antibiotics - dogs - antibacterial

Irland - engelsk - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - betamethasone dipropionate, clotrimazole - cream - 0.064/1.0 - corticosteroids, potent, combinations with antibiotics

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - clotrimazole; betamethasone dipropionate - cutaneous cream - 10mg/1gram ; 640microgram/1gram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - clotrimazole; betamethasone dipropionate - cutaneous cream - 10mg/1gram ; 640microgram/1gram